Ligand validation:5HYA

MYS: PENTADECANE

MYS is a Ligand Of Interest in 5HYA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5HYA_MYS_A_413	42%	93%	0.144	0.9	0.12	0.36	-	-	1	0	80%	1
5HYA_MYS_A_418	36%	88%	0.163	0.855	0.1	0.56	-	-	1	0	100%	1
5HYA_MYS_A_414	21%	87%	0.178	0.849	0.12	0.56	-	-	0	0	67%	1
5HYA_MYS_A_419	21%	91%	0.19	0.812	0.09	0.47	-	-	4	0	93%	1
5HYA_MYS_A_417	17%	93%	0.2	0.779	0.11	0.36	-	-	0	0	100%	1
5HYA_MYS_A_421	10%	93%	0.251	0.767	0.09	0.37	-	-	0	0	93%	1
5HYA_MYS_A_416	9%	93%	0.163	0.775	0.16	0.3	-	-	0	0	33%	1
5HYA_MYS_A_412	9%	91%	0.19	0.677	0.09	0.46	-	-	0	0	100%	1
5HYA_MYS_A_420	5%	94%	0.166	0.696	0.17	0.28	-	-	0	0	33%	1
3V5U_MYS_A_714	31%	66%	0.156	0.858	0.41	0.88	-	-	3	0	80%	1
5HXH_MYS_A_404	30%	70%	0.142	0.923	0.45	0.7	-	-	0	0	33%	1
5JDG_MYS_A_423	26%	69%	0.154	0.927	0.44	0.73	-	-	0	0	27%	1
5HXE_MYS_A_410	24%	69%	0.183	0.81	0.37	0.83	-	-	0	0	100%	1
5HWY_MYS_A_414	23%	69%	0.157	0.911	0.43	0.74	-	-	0	0	27%	1
6GAD_MYS_A_308	71%	76%	0.088	0.908	0.09	0.85	-	-	0	0	100%	1
6GAE_MYS_A_308	68%	76%	0.089	0.9	0.09	0.85	-	-	0	0	100%	1
6GAC_MYS_A_308	67%	76%	0.089	0.896	0.09	0.85	-	-	0	0	100%	1
6GAG_MYS_A_308	67%	76%	0.091	0.897	0.09	0.85	-	-	0	0	100%	1
6GA9_MYS_A_308	66%	76%	0.094	0.898	0.09	0.85	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.